DelveInsight’s X-Linked Retinitis Pigmentosa epidemiology forecast report provides a comprehensive understanding of X-Linked Retinitis Pigmentosa, historical and forecasted epidemiology, and X-Linked Retinitis Pigmentosa trends in the 7MM (the United States, EU5 (France, Italy, Spain, the UK, and Germany), and Japan).
Key Takeaways from the X-Linked Retinitis Pigmentosa Epidemiology Forecast Report
-
As per DelveInsight estimates, the total X-Linked Retinitis Pigmentosa prevalent cases was 250,911 in the 7MM in 2020, and it is expected to rise at a CAGR of 0.52% by 2030.
-
Among the EU5 countries, Germany has the highest X-Linked Retinitis Pigmentosa diagnosed cases, while Spain had the least in 2020.
-
Among the numerous XLRP mutations, RPGR is the most frequent in Japan in 2020.
-
According to DelveInsight XLRP epidemiology analysis, Non-Syndromic Retinitis Pigmentosa is more common than Syndromic and Systemic Retinitis Pigmentosa.
To learn more about the symptoms, diagnosis, and treatment, request for sample @ X-Linked Retinitis Pigmentosa Treatment
X-Linked Retinitis Pigmentosa: Overview
X-Linked Retinitis Pigmentosa (XLRP) is severe genetic photoreceptor dystrophy that causes blindness at a median age of 45 years. Hence it mainly affects men. XLRP is linked to X chromosome gene mutations. The mutant gene is carried by mothers on one of their X chromosomes and passed on to their sons in this kind of inheritance.
X-Linked Retinitis Pigmentosa Epidemiology Segmentation
The X-Linked Retinitis Pigmentosa report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
-
Retinitis Pigmentosa Total Prevalence
-
Retinitis Pigmentosa Diagnosed Prevalence
-
Retinitis Pigmentosa Type-Specific Diagnosed Prevalence
-
X-Linked Retinitis Pigmentosa Gene Mutation Specific Cases
Get a detailed analysis of epidemiology segmentation @ X-Linked Retinitis Pigmentosa Epidemiology
Table of Contents
|
1. |
Key Insights |
|
2. |
Report Introduction |
|
3. |
X-Linked Retinitis Pigmentosa (XLRP) Epidemiology Overview at a Glance |
|
4. |
Executive Summary of X-linked Retinitis Pigmentosa (XLRP) |
|
5. |
X-Linked Retinitis Pigmentosa: Disease Background and Overview |
|
6. |
X-Linked Retinitis Pigmentosa Epidemiology and Patient Population |
|
7. |
Patient Journey |
|
8. |
KOL Views |
|
9. |
Appendix |
|
10. |
DelveInsight Capabilities |
|
11. |
Disclaimer |
|
12. |
About DelveInsight |
For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts
Related Reports
Retinitis Pigmentosa Epidemiology Forecast
DelveInsight’s ‘Retinitis Pigmentosa (RP) – Epidemiology Forecast to 2030’ report explains the disease’s historical and forecasted Retinitis Pigmentosa (RP) epidemiology in the 7MM.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/